In cross-sectional studies, these CF patients with a high 1h-OGTT glucose value (G60) or low plasma insulin value (I60) present reduced pulmonary function and/or weight, as observed in patients with de novo CFRD diagnosis [12–15]. This evidence concerns the gene INS and cystic fibrosis-related diabetes.